Initiation of Apixaban Versus Warfarin in Patients With Kidney Failure on Hemodialysis With Newly Diagnosed Atrial Fibrillation: A Target Trial Emulation

Patients with kidney failure on hemodialysis (KFHD) and atrial fibrillation (AF) are at high risk of ischemic stroke. Oral anticoagulation (OAC) may reduce this risk but at the expense of excess bleeding. We emulated a randomized comparative effectiveness trial of apixaban versus warfarin initiation in patients with KFHD and newly diagnosed AF.